phloretin and rutin
phloretin has been researched along with rutin in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 1 (14.29) | 29.6817 |
| 2010's | 5 (71.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Constantinou, A; Mehta, R; Moon, R; Rao, K; Runyan, C; Vaughan, A | 1 |
| Domina, NG; Khlebnikov, AI; Kirpotina, LN; Quinn, MT; Schepetkin, IA | 1 |
| Amić, D; Lucić, B | 1 |
| Maccari, R; Ottanà, R | 1 |
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
| Abe, H; Adachi, I; Horino, Y; Kesamaru, H; Nose, T; Suyama, K; Tomohara, K | 1 |
| Aguiñiga-Sánchez, I; Aguirre-Medina, JF; Cadena-Iñiguez, J; Rivera-Martínez, AR; Ruiz-Posadas, LDM; Salazar-Aguilar, S; Santiago-Osorio, E; Soto-Hernández, M | 1 |
Other Studies
7 other study(ies) available for phloretin and rutin
| Article | Year |
|---|---|
Flavonoids as DNA topoisomerase antagonists and poisons: structure-activity relationships.
Topics: DNA Damage; DNA Topoisomerases, Type I; DNA Topoisomerases, Type II; Electrophoresis, Agar Gel; Flavonoids; Hydroxylation; Plasmids; Protein Conformation; Structure-Activity Relationship; Topoisomerase I Inhibitors; Topoisomerase II Inhibitors | 1995 |
Improved quantitative structure-activity relationship models to predict antioxidant activity of flavonoids in chemical, enzymatic, and cellular systems.
Topics: Animals; Antioxidants; Drug Design; Flavonoids; Humans; Phagocytes; Phenols; Polyphenols; Quantitative Structure-Activity Relationship | 2007 |
Reliability of bond dissociation enthalpy calculated by the PM6 method and experimental TEAC values in antiradical QSAR of flavonoids.
Topics: Flavonoids; Free Radical Scavengers; Models, Biological; Quantitative Structure-Activity Relationship; Quantum Theory; Software; Thermodynamics | 2010 |
Low molecular weight phosphotyrosine protein phosphatases as emerging targets for the design of novel therapeutic agents.
Topics: Animals; Antineoplastic Agents; Antitubercular Agents; Diabetes Mellitus; Humans; Hypoglycemic Agents; Insulin Resistance; Isoenzymes; Models, Molecular; Molecular Targeted Therapy; Mycobacterium tuberculosis; Neoplasms; Protein Conformation; Protein Tyrosine Phosphatases; Proto-Oncogene Proteins | 2012 |
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |
DMSO-Perturbing Assay for Identifying Promiscuous Enzyme Inhibitors.
Topics: | 2019 |
Sechium edule (Jacq.) Swartz, a New Cultivar with Antiproliferative Potential in a Human Cervical Cancer HeLa Cell Line.
Topics: Antineoplastic Agents, Phytogenic; Apigenin; Cell Proliferation; Cucurbitaceae; Cucurbitacins; Female; Flavanones; Flavonoids; Fruit; HeLa Cells; Humans; Inhibitory Concentration 50; Phloretin; Phytochemicals; Plant Extracts; Quercetin; Rutin; Uterine Cervical Neoplasms | 2017 |